Casodex 150-mg Compassionate Use Trial for Subjects With Prostate Cancer

Expanded access is no longer available for this treatment.
Information provided by AstraZeneca

Please refer to this study by its ClinicalTrials.gov identifier: NCT00636259

Sponsors and Collaborators